174 related articles for article (PubMed ID: 16368578)
1. Audit of intrapartum group B streptococcus prophylaxis.
Rajagopalan C; Perry M; Owen P
J Obstet Gynaecol; 2005 Nov; 25(8):754-5. PubMed ID: 16368578
[TBL] [Abstract][Full Text] [Related]
2. A complete audit cycle of intrapartum group B streptococcus prophylaxis.
McCord N; Owen P; Powls A; Lunan B
Health Bull (Edinb); 2001 Jul; 59(4):263-7. PubMed ID: 12664737
[TBL] [Abstract][Full Text] [Related]
3. Neonatal early-onset group B streptococcal disease in the era of intrapartum chemoprophylaxis: residual problems.
Pinto NM; Soskolne EI; Pearlman MD; Faix RG
J Perinatol; 2003 Jun; 23(4):265-71. PubMed ID: 12774131
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease.
Lin FY; Brenner RA; Johnson YR; Azimi PH; Philips JB; Regan JA; Clark P; Weisman LE; Rhoads GG; Kong F; Clemens JD
Am J Obstet Gynecol; 2001 May; 184(6):1204-10. PubMed ID: 11349189
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of early-onset neonatal group B streptococcal infection: implications for screening.
Konrad G; Katz A
Can Fam Physician; 2007 Jun; 53(6):1055, 2001:e.1-6, 1054. PubMed ID: 17872785
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of intrapartum chemoprophylaxis less than 4 hours duration.
Berardi A; Rossi C; Biasini A; Minniti S; Venturelli C; Ferrari F; Facchinetti F
J Matern Fetal Neonatal Med; 2011 Apr; 24(4):619-25. PubMed ID: 20828241
[TBL] [Abstract][Full Text] [Related]
7. Early-onset group B streptococcal disease in the era of maternal screening.
Puopolo KM; Madoff LC; Eichenwald EC
Pediatrics; 2005 May; 115(5):1240-6. PubMed ID: 15867030
[TBL] [Abstract][Full Text] [Related]
8. Association of intrapartum antibiotic exposure and late-onset serious bacterial infections in infants.
Glasgow TS; Young PC; Wallin J; Kwok C; Stoddard G; Firth S; Samore M; Byington CL
Pediatrics; 2005 Sep; 116(3):696-702. PubMed ID: 16140710
[TBL] [Abstract][Full Text] [Related]
9. Intrapartum antibiotic prophylaxis for Group B Streptococcus: has the time come to wait more than 4 hours?
Turrentine M
Am J Obstet Gynecol; 2014 Jul; 211(1):15-7. PubMed ID: 24315859
[TBL] [Abstract][Full Text] [Related]
10. Compliance with a risk factor-based intrapartum prophylaxis program for neonatal group B streptococcal disease.
McIlwaine K; Kneebone K; Barkehall-Thomas A; Wallace EM
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):199-201. PubMed ID: 16704472
[TBL] [Abstract][Full Text] [Related]
11. Intrapartum group B streptococci prophylaxis in patients reporting a penicillin allergy.
Matteson KA; Lievense SP; Catanzaro B; Phipps MG
Obstet Gynecol; 2008 Feb; 111(2 Pt 1):356-64. PubMed ID: 18238973
[TBL] [Abstract][Full Text] [Related]
12. Group B streptococcus disease in neonates: to screen or not to screen?
Subair O; Wagner P; Omojole F; Morgan H
J Obstet Gynaecol; 2005 Jul; 25(5):462-4. PubMed ID: 16183581
[TBL] [Abstract][Full Text] [Related]
13. "Real World" compliance with strategies to prevent early-onset group B streptococcal disease.
Riley L; Appollon K; Haider S; Chan-Flynn S; Cohen A; Ecker J; Rein M; Lieberman E
J Perinatol; 2003 Jun; 23(4):272-7. PubMed ID: 12774132
[TBL] [Abstract][Full Text] [Related]
14. [Antibiotic treatment of women with group B Steptococci during delivery?].
Kløvstad H; Høiby EA; Aavitsland P
Tidsskr Nor Laegeforen; 2008 Nov; 128(21):2467-9. PubMed ID: 19096471
[TBL] [Abstract][Full Text] [Related]
15. Impact of intrapartum antibiotics on the care and evaluation of the neonate.
Balter S; Zell ER; O'Brien KL; Roome A; Noga H; Thayu M; Schuchat A
Pediatr Infect Dis J; 2003 Oct; 22(10):853-7. PubMed ID: 14551483
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of a strategy to prevent neonatal early-onset group B streptococcal (GBS) sepsis.
Renner RM; Renner A; Schmid S; Hoesli I; Nars P; Holzgreve W; Surbek DV
J Perinat Med; 2006; 34(1):32-8. PubMed ID: 16489884
[TBL] [Abstract][Full Text] [Related]
17. The prevention of early-onset neonatal group B streptococcus infection: technical report from the New Zealand GBS Consensus Working Party.
Campbell N; Eddy A; Darlow B; Stone P; Grimwood K;
N Z Med J; 2004 Aug; 117(1200):U1023. PubMed ID: 15475993
[TBL] [Abstract][Full Text] [Related]
18. Maternal group B streptococcus infection, neonatal outcome and the role of preventive strategies.
Elvedi-Gasparović V; Peter B
Coll Antropol; 2008 Mar; 32(1):147-51. PubMed ID: 18494200
[TBL] [Abstract][Full Text] [Related]
19. Pilot study to prevent early-onset Group B Streptococcal disease in newborns.
Jefferson UT
Adv Neonatal Care; 2006 Aug; 6(4):208-19. PubMed ID: 16890133
[TBL] [Abstract][Full Text] [Related]
20. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis.
Chen KT; Puopolo KM; Eichenwald EC; Onderdonk AB; Lieberman E
Am J Obstet Gynecol; 2005 Apr; 192(4):1167-71. PubMed ID: 15846197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
